- The trend backdrop is active with a 22-week active streak.
- Volume is elevated versus the 13-week average, confirming attention.
OBSRV
OSL
Week ended 07 Aug 2026
Weekly Investor Report
Observe Medical ASA · Healthcare · Medical Devices
Latest close
0.98 NOK
-2.0%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is -2.8% below the Trend Line and sits at 52.6% of its 52-week range. The latest completed week returned -2.0%, after a -9.3% four-week move. The latest news-sentiment score is 50/100.
Setup score
41
out of 100
Latest Close
0.98 NOK
7 Aug 2026
1W Return
-2.0%
latest completed week
4W Return
-9.3%
short-term follow-through
12W Return
-10.1%
quarterly tape
Trend Breadth
42.3%
22 of 52 weeks active
Volume Ratio
1.9x
vs 13-week average
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 42.03% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.0%
Latest completed week; four-week move -9.3%.
Indicator stack
68/28
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.03%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
12 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is -2.8% below the Trend Line and sits at 52.6% of its 52-week range. The latest completed week returned -2.0%, after a -9.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4512-week average 0.55
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.45Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -9.3% over four weeks, -10.1% over 12 weeks, and -1.0% over one year. The current trend has remained active for 22 consecutive weeks.
Performance by holding period
Active trend streak22 weeks
Active weeks in one year22
Trend breadth42.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.80Latest activity-pressure read.
Pressure change-91.8%Four-week change in activity pressure.
Leadership-1.32Latest relative-leadership reading.
RS change-111.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 12 relevant articles.
0 positive · 12 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.5%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+34.8%Week of 20 Mar.
Worst week-18.6%Week of 6 Mar.
Latest week-2.0%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains4
Flat weeks0
Modest losses6
Sharp losses9
Recent vol5.1%13-week weekly-return volatility.
Base vol12.5%52-week weekly-return volatility.
Up/down split19/31Count of positive and negative weeks in the 52-week window.
Average skew13.6% / -7.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNO Healthcare
4-week rank22 / 24
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD37.5%positive activity pressure
RS29.2%positive relative leadership
Four-week leaders
IndustryNO Medical Devices
4-week rank4 / 4
Group average3.3%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape45/100
Trend, activity pressure, participation, and risk combine to a 45/100 tape read.
Indicator analysis61/100Latest 12-week confirmation: trend 12/12, activity pressure 3/12, relative leadership 9/12.
Activity pressure 0.45; No reversal markers Next-Week ExpectancyNegative 42.03%Next-week expectancy is negative with a 42.03% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 12 relevant articles.
Medical Devices & Supplies - Diversified Stocks Q2 Results: Benchmarking Neogen (NASDAQ:NEOG) Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.98 NOK | -2.0% | 1.01 NOK | 4.09 NOK | -0.80 | -1.32 | 1.2M | On |
| 31 Jul 2026 | 1.00 NOK | -7.8% | 1.00 NOK | 4.15 NOK | -0.68 | 0.59 | 571.8K | On |
| 24 Jul 2026 | 1.08 NOK | 5.9% | 0.99 NOK | 4.23 NOK | -0.60 | 9.04 | 349.9K | On |
| 17 Jul 2026 | 1.02 NOK | -5.1% | 0.98 NOK | 4.27 NOK | -0.61 | 4.88 | 423.8K | On |
| 10 Jul 2026 | 1.08 NOK | -3.1% | 0.97 NOK | 4.31 NOK | -0.42 | 11.13 | 349.1K | On |
| 3 Jul 2026 | 1.11 NOK | -3.0% | 0.96 NOK | 4.35 NOK | -0.33 | 12.91 | 100.7K | On |
| 26 Jun 2026 | 1.15 NOK | 0.9% | 0.95 NOK | 4.39 NOK | -0.26 | 18.93 | 340.4K | On |
| 19 Jun 2026 | 1.14 NOK | 2.7% | 0.93 NOK | 4.47 NOK | -0.21 | 13.93 | 141.1K | On |
| 12 Jun 2026 | 1.11 NOK | -1.3% | 0.91 NOK | 4.56 NOK | -0.17 | 8.69 | 151.6K | On |
| 5 Jun 2026 | 1.12 NOK | 11.9% | 0.89 NOK | 4.66 NOK | 0.06 | 9.82 | 836.2K | On |
| 29 May 2026 | 1.00 NOK | -3.8% | 0.87 NOK | 4.77 NOK | 0.39 | -2.25 | 2.1M | On |
| 22 May 2026 | 1.04 NOK | -4.1% | 0.86 NOK | 4.88 NOK | 0.78 | -1.70 | 782.3K | On |
| 15 May 2026 | 1.09 NOK | 3.3% | 0.85 NOK | 5.00 NOK | 1.14 | 2.98 | 1.0M | On |
| 8 May 2026 | 1.05 NOK | -6.6% | 0.84 NOK | 5.11 NOK | 1.27 | 0.92 | 1.1M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.